Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
10,045,218
-
Shares change
-
-94,974
-
Total reported value, excl. options
-
$26,830,365
-
Value change
-
-$333,937
-
Put/Call ratio
-
51%
-
Number of buys
-
16
-
Number of sells
-
-33
-
Price
-
$2.67
Significant Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q3 2020
78 filings reported holding GALT - GALECTIN THERAPEUTICS INC - COM NEW as of Q3 2020.
GALECTIN THERAPEUTICS INC - COM NEW (GALT) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,045,218 shares
.
Largest 10 shareholders include BlackRock Inc. (2,503,111 shares), VANGUARD GROUP INC (1,849,255 shares), ADVISOR GROUP HOLDINGS, INC. (1,035,821 shares), D.A. DAVIDSON & CO. (853,716 shares), STATE STREET CORP (698,113 shares), GEODE CAPITAL MANAGEMENT, LLC (594,621 shares), NORTHERN TRUST CORP (465,964 shares), Cambridge Investment Research Advisors, Inc. (191,195 shares), Cutter & CO Brokerage, Inc. (184,742 shares), and Nuveen Asset Management, LLC (181,886 shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.